Cancer-causing contaminant in over-the-counter remedy is used by millions for acid reflux and heartburn
Oct 1, 2019
| CNN – CVS Pharmacy and Walgreens are no longer selling Zantac, as well as generic version of the heartburn medication, over concerns that they might contain a substance that could cause cancer.
CVS, the largest pharmacy chain in the country, said over the weekend it was suspending sale of Zantac and other products which contain ranitidine until further notice.
Walgreens said in a statement it is removing the medications from shelves while the US Food and Drug Administration continues its review of the products.
The FDA said earlier this month that it has learned that some ranitidine medications — including those known by the brand name Zantac — contain low levels of an impurity that could cause cancer. [Bloomberg reported last month that Zantac is manufactured in India. See report below on troubling history of Sandoz products made in India. – Ed.]
Zantac and its CVS-branded generic counterpart have not been recalled, a statement from CVS said, and the FDA has not recommended that patients stop taking ranitidine products.
Customers who have already bought the products can return them to CVS for a refund, CVS said.
Drugmaker Sandoz is recalling ranitidine hydrochloride capsules in the United States because of confirmed contamination with the probable human carcinogen. Read more.
Contaminated Drugs From India A Recurring Problem With Sandoz
Sandoz Recalls Drugs Made at Mylan India Site
Source: Economic Times of India
Feb 25, 2016
U.S.-based Sandoz, the generic pharmaceuticals division of Novartis, is recalling 270,000 bottles of hypertension tablets, manufactured by Hyderabad (India)-based Mylan Laboratories, from the American market.
The recall involves bottles of Candesartan Cilexetil tablets that failed to meet impurities/degradation specifications and 9-month stability time point.
Candesartan Cilexetil is a generic verison of AstraZeneca’s blood pressure drug Atacand.
In November 2015, Sandoz recalled the same drug manufactured from the same Mylan facility, for similar reasons. Source.